(8,804)Basic net loss per common share$
(0.16)Diluted net loss per common share$
(0.16)Shares used in computing basic net loss per common share56,460,82955,554,579Shares used in computing diluted net loss per common share56,460,82955,554,579
DEPOMED, INC.CONDENSED BALANCE SHEETS(in thousands)March 31,December 31,20132012(Unaudited)(1)Cash, cash equivalents and marketable securities$
77,892Accounts receivable, net5,2923,614Receivables from collaborative partners 10,01510,078Inventories8,7439,587Property and equipment, net8,0908,237Intangible assets, net24,46725,078Prepaid and other assets5,9327,167Total Assets$
141,653Accounts payable and accrued liabilities$
32,578Deferred license revenue17,79718,789Other liabilities9,4496,350Shareholders' equity80,25683,936Total liabilities and shareholders' equity $
141,653(1) Derived from the audited financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012.
|SOURCE Depomed, Inc.|
Copyright©2012 PR Newswire.
All rights reserved